Seek Returns logo

A vs. PHG: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at A and PHG, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

A is a standard domestic stock, while PHG trades as New York Registered Shares, providing U.S. investors with a way to invest in the foreign-based company.

SymbolAPHG
Company NameAgilent Technologies, Inc.Koninklijke Philips N.V.
CountryUnited StatesNetherlands
GICS SectorHealth CareHealth Care
GICS IndustryLife Sciences Tools & ServicesHealth Care Equipment & Supplies
Market Capitalization33.83 billion USD26.43 billion USD
ExchangeNYSENYSE
Listing DateNovember 18, 1999March 17, 1980
Security TypeCommon StockNY Reg Shrs

Historical Performance

This chart compares the performance of A and PHG by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

A vs. PHG: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolAPHG
5-Day Price Return-0.15%1.54%
13-Week Price Return5.57%12.47%
26-Week Price Return-13.01%-12.21%
52-Week Price Return-14.23%-11.79%
Month-to-Date Return4.62%2.68%
Year-to-Date Return-10.59%-2.79%
10-Day Avg. Volume1.08M1.10M
3-Month Avg. Volume1.89M1.84M
3-Month Volatility27.93%28.64%
Beta1.271.05

Profitability

Return on Equity (TTM)

A

19.46%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.55%
Median
6.22%
Q1
3.86%
Min
-6.95%

In the upper quartile for the Life Sciences Tools & Services industry, A’s Return on Equity of 19.46% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

PHG

-0.18%

Health Care Equipment & Supplies Industry

Max
34.53%
Q3
19.38%
Median
9.52%
Q1
4.86%
Min
-7.58%

PHG has a negative Return on Equity of -0.18%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.

A vs. PHG: A comparison of their Return on Equity (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Net Profit Margin (TTM)

A

17.59%

Life Sciences Tools & Services Industry

Max
27.28%
Q3
16.17%
Median
7.24%
Q1
3.00%
Min
-3.05%

A Net Profit Margin of 17.59% places A in the upper quartile for the Life Sciences Tools & Services industry, signifying strong profitability and more effective cost management than most of its peers.

PHG

0.90%

Health Care Equipment & Supplies Industry

Max
23.34%
Q3
13.06%
Median
9.53%
Q1
5.96%
Min
-3.87%

Falling into the lower quartile for the Health Care Equipment & Supplies industry, PHG’s Net Profit Margin of 0.90% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

A vs. PHG: A comparison of their Net Profit Margin (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Operating Profit Margin (TTM)

A

21.36%

Life Sciences Tools & Services Industry

Max
33.15%
Q3
19.34%
Median
13.02%
Q1
8.05%
Min
-4.38%

An Operating Profit Margin of 21.36% places A in the upper quartile for the Life Sciences Tools & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

PHG

6.11%

Health Care Equipment & Supplies Industry

Max
29.44%
Q3
17.80%
Median
13.95%
Q1
8.73%
Min
-3.56%

PHG’s Operating Profit Margin of 6.11% is in the lower quartile for the Health Care Equipment & Supplies industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

A vs. PHG: A comparison of their Operating Profit Margin (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Profitability at a Glance

SymbolAPHG
Return on Equity (TTM)19.46%-0.18%
Return on Assets (TTM)9.94%-0.08%
Net Profit Margin (TTM)17.59%0.90%
Operating Profit Margin (TTM)21.36%6.11%
Gross Profit Margin (TTM)53.77%43.85%

Financial Strength

Current Ratio (MRQ)

A

2.09

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.77
Median
1.85
Q1
1.40
Min
0.43

A’s Current Ratio of 2.09 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.

PHG

1.26

Health Care Equipment & Supplies Industry

Max
4.90
Q3
3.05
Median
2.14
Q1
1.49
Min
0.86

PHG’s Current Ratio of 1.26 falls into the lower quartile for the Health Care Equipment & Supplies industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

A vs. PHG: A comparison of their Current Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Debt-to-Equity Ratio (MRQ)

A

0.57

Life Sciences Tools & Services Industry

Max
1.75
Q3
0.83
Median
0.41
Q1
0.18
Min
0.00

A’s Debt-to-Equity Ratio of 0.57 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

PHG

0.81

Health Care Equipment & Supplies Industry

Max
1.49
Q3
0.71
Median
0.45
Q1
0.14
Min
0.00

PHG’s leverage is in the upper quartile of the Health Care Equipment & Supplies industry, with a Debt-to-Equity Ratio of 0.81. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

A vs. PHG: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Interest Coverage Ratio (TTM)

A

254.50

Life Sciences Tools & Services Industry

Max
29.61
Q3
23.24
Median
6.07
Q1
2.18
Min
-14.08

With an Interest Coverage Ratio of 254.50, A demonstrates a superior capacity to service its debt, placing it well above the typical range for the Life Sciences Tools & Services industry. This stems from either robust earnings or a conservative debt load.

PHG

1.41

Health Care Equipment & Supplies Industry

Max
58.29
Q3
25.56
Median
9.06
Q1
3.60
Min
-28.92

In the lower quartile for the Health Care Equipment & Supplies industry, PHG’s Interest Coverage Ratio of 1.41 indicates a tighter cushion for servicing debt, suggesting less financial flexibility than many of its competitors.

A vs. PHG: A comparison of their Interest Coverage Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Financial Strength at a Glance

SymbolAPHG
Current Ratio (MRQ)2.091.26
Quick Ratio (MRQ)1.600.81
Debt-to-Equity Ratio (MRQ)0.570.81
Interest Coverage Ratio (TTM)254.501.41

Growth

Revenue Growth

A vs. PHG: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

A vs. PHG: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

A

0.82%

Life Sciences Tools & Services Industry

Max
1.80%
Q3
0.78%
Median
0.37%
Q1
0.00%
Min
0.00%

With a Dividend Yield of 0.82%, A offers a more attractive income stream than most of its peers in the Life Sciences Tools & Services industry, signaling a strong commitment to shareholder returns.

PHG

0.00%

Health Care Equipment & Supplies Industry

Max
4.05%
Q3
1.76%
Median
0.71%
Q1
0.00%
Min
0.00%

PHG’s Dividend Yield of 0.00% is consistent with its peers in the Health Care Equipment & Supplies industry, providing a dividend return that is standard for its sector.

A vs. PHG: A comparison of their Dividend Yield (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Dividend Payout Ratio (TTM)

A

23.76%

Life Sciences Tools & Services Industry

Max
156.00%
Q3
65.73%
Median
23.81%
Q1
0.00%
Min
0.00%

A’s Dividend Payout Ratio of 23.76% is within the typical range for the Life Sciences Tools & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

PHG

0.42%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
72.47%
Median
27.49%
Q1
0.00%
Min
0.00%

PHG’s Dividend Payout Ratio of 0.42% is within the typical range for the Health Care Equipment & Supplies industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

A vs. PHG: A comparison of their Dividend Payout Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Dividend at a Glance

SymbolAPHG
Dividend Yield (TTM)0.82%0.00%
Dividend Payout Ratio (TTM)23.76%0.42%

Valuation

Price-to-Earnings Ratio (TTM)

A

29.14

Life Sciences Tools & Services Industry

Max
117.96
Q3
65.59
Median
37.26
Q1
27.51
Min
1.73

A’s P/E Ratio of 29.14 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

PHG

140.05

Health Care Equipment & Supplies Industry

Max
73.48
Q3
51.69
Median
34.31
Q1
25.74
Min
11.47

At 140.05, PHG’s P/E Ratio is exceptionally high, exceeding the typical maximum for the Health Care Equipment & Supplies industry. This suggests the stock may be significantly overvalued compared to its peers and implies high market expectations that could be difficult to meet.

A vs. PHG: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Price-to-Sales Ratio (TTM)

A

5.13

Life Sciences Tools & Services Industry

Max
12.46
Q3
6.70
Median
4.24
Q1
2.68
Min
0.73

A’s P/S Ratio of 5.13 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

PHG

1.26

Health Care Equipment & Supplies Industry

Max
9.53
Q3
5.26
Median
3.39
Q1
2.13
Min
0.00

In the lower quartile for the Health Care Equipment & Supplies industry, PHG’s P/S Ratio of 1.26 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

A vs. PHG: A comparison of their Price-to-Sales Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Price-to-Book Ratio (MRQ)

A

5.00

Life Sciences Tools & Services Industry

Max
7.99
Q3
4.69
Median
3.30
Q1
1.88
Min
1.02

A’s P/B Ratio of 5.00 is in the upper tier for the Life Sciences Tools & Services industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

PHG

1.89

Health Care Equipment & Supplies Industry

Max
10.85
Q3
5.98
Median
3.48
Q1
2.43
Min
0.69

PHG’s P/B Ratio of 1.89 is in the lower quartile for the Health Care Equipment & Supplies industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

A vs. PHG: A comparison of their Price-to-Book Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Valuation at a Glance

SymbolAPHG
Price-to-Earnings Ratio (TTM)29.14140.05
Price-to-Sales Ratio (TTM)5.131.26
Price-to-Book Ratio (MRQ)5.001.89
Price-to-Free Cash Flow Ratio (TTM)28.5814.66